Amarin: It’s all too Obvious?

Photo by Sebastian Pena Lambarri on Unsplash

Introduction

Followers of Amarin, whether close or casual, have witnessed an eventful story unfold in recent times. In 2018, the then-microcap company was all but an afterthought. Then, and still, a one drug company, that drug, VASCEPA, was anything but a breakout star. With its only approved use for a limited patient population, and for a limited purpose, Vascepa sales were lackluster.